Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer

被引:9
|
作者
Liang, Bin [1 ]
Shao, Yang [1 ]
Long, Fei [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; NETWORK; GEMCITABINE; PROTEINS; DATABASE; PATHWAY; RISK;
D O I
10.1155/2016/3952494
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lung cancer is the primary reason for death due to cancer worldwide, and non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer. Most patients die from complications of NSCLC due to poor diagnosis. In this paper, we aimed to predict gene biomarkers that may be of use for diagnosis of NSCLC by integrating differential gene expression analysis with functional association network analysis. We first constructed an NSCLC-specific functional association network by combining gene expression correlation with functional association. Then, we applied a network partition algorithm to divide the network into gene modules and identify the most NSCLC-specific gene modules based on their differential expression pattern in between normal and NSCLC samples. Finally, from these modules, we identified genes that exhibited the most impact on the expression of their functionally associated genes in between normal and NSCLC samples and predicted them as NSCLC biomarkers. Literature review of the top predicted gene biomarkers suggested that most of them were already considered critical for development of NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Gemcitabine: A reality in the treatment of non-small-cell lung cancer
    Rinaldi, M
    TUMORI, 1997, 83 (06) : S3 - S7
  • [42] Cetuximab and non-small-cell lung cancer: end of the story?
    Rossi, Antonio
    LANCET ONCOLOGY, 2013, 14 (13) : 1251 - 1253
  • [43] A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer
    Liu, Kun
    Chen, Hong-Lin
    Gu, Ming-Ming
    You, Qing-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (12): : 16081 - 16088
  • [44] Treatment of advanced non-small-cell lung cancer in the elderly
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Ferrara, Marianna Luciana
    Castaldo, Vincenzo
    Palazzolo, Giovanni
    Mazzeo, Nicole
    LUNG CANCER, 2009, 66 (03) : 282 - 286
  • [45] Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Kasahara, Norimitsu
    Sakurai, Reiko
    CANCERS, 2021, 13 (23)
  • [46] Incidence of hippocampal metastases in non-small-cell lung cancer
    Ly, Sophia
    Lehman, Margot
    Liu, Howard
    Hukins, Craig
    Murphy, Michelle
    Dauth, Margaret
    Devine, Matthew S.
    Mai, Gang Tao
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 586 - 590
  • [47] Rare site of metastasis of non-small-cell lung cancer
    Stathopoulos, G. P.
    Rigatos, S. K.
    JOURNAL OF BUON, 2010, 15 (01): : 189 - 190
  • [48] Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers
    Qin, Xiuxiu
    Chen, Ruoshi
    Xiong, Rui
    Tan, Zimiao
    Gao, Shanshan
    Lin, Chunshui
    Huo, Tianming
    FUTURE ONCOLOGY, 2019, 15 (27) : 3135 - 3148
  • [49] Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients
    Sullivan, Ivana
    Riera, Pau
    Andres, Marta
    Altes, Albert
    Majem, Margarita
    Blanco, Remei
    Capdevila, Laia
    Barba, Andres
    Barnadas, Agusti
    Salazar, Juliana
    ANGIOGENESIS, 2019, 22 (03) : 433 - 440
  • [50] Effect and biomarker of Nivolumab for non-small-cell lung cancer
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Ul Rehman, Faisal
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117